Morphic Holding (MORF) S-8 Registration of securities for employees

As filed with the Securities and Exchange Commission on February 24, 2022

Registration No. 333-

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM S-8

REGISTRATION STATEMENT

UNDER THE

SECURITIES ACT OF 1933

MORPHIC HOLDING, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of Incorporation or Organization) 47-3878772 (I.R.S. Employer Identification No.)

35 Gatehouse Drive, A2

Waltham, Massachusetts 02451

(781) 996-0955

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

2019 Equity Incentive Plan

2019 Employee Stock Purchase Plan

(Full title of the plans)

Praveen P. Tipirneni, M.D.

President and Chief Executive Officer

Morphic Holding, Inc.

35 Gatehouse Drive, A2

Waltham, Massachusetts 02451

(781) 996-0955

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Please send copies of all communications to:

Effie Toshav, Esq.

Robert Freedman, Esq.

Julia Forbess, Esq.

Fenwick & West LLP

555 California Street, 12th Floor

San Francisco, California 94104

(415) 875-2300

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Exchange Act. ☐

REGISTRATION OF ADDITIONAL SHARES

PURSUANT TO GENERAL INSTRUCTION E

Morphic Holding, Inc. (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register (a) 1,483,415 additional shares of common stock available for issuance under the Registrant’s 2019 EIP, pursuant to the provision of the 2019 EIP providing for an annual 4% automatic increase in the number of shares reserved for issuance and (b) 370,853 additional shares of common stock available for issuance under the Registrant’s 2019 ESPP, pursuant to the provision of the 2019 ESPP providing for an annual 1% automatic increase in the number of shares reserved for issuance.

    In accordance with General Instruction E of Form S-8, and only with respect to the common stock issuable under the 2019 EIP and 2019 ESPP, this Registration Statement hereby incorporates by reference the contents of the Registrant’s Registration Statements on Form S-8 filed with the Commission on June 27, 2019 (Registration No. 333-232372), on February 27, 2020 (Registration No. 333-236727) and on March 1, 2021 (Registration No. 333-253678), to the extent not superseded hereby.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents filed by the Registrant with the Commission pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are incorporated herein by reference:

(a)    the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Commission on February 24, 2022 pursuant to Section 13 of the Exchange Act;

(b)    all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant’s Annual Report on Form 10-K referred to in (a) above; and

(c)     The description of the Registrant’s common stock contained in the Registrant’s registration statement on Form 8-A (File No. 001-38940) filed on June 14, 2019 under Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.

All documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such documents, except as to specific sections of such documents as set forth therein. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement.

Item 5. Interests of Named Experts and Counsel.

Not applicable.

Item 8. Exhibits.

The following exhibits are filed herewith:

Exhibit Number	Exhibit Description	Incorporated by Reference Form	File No.	Exhibit	Filing Date	Filed Herewith
4.1	Restated Certificate of Incorporation of the Registrant	10-Q	001-38940	3.1	8/13/2019
4.2	Restated Bylaws of the Registrant as amended	10-Q	001-38940	3.2	5/6/2020
4.3	Form of Registrant's Common Stock certificate	S-1/A	333-231837	4.1	6/14/2019
5.1	Opinion of Fenwick & West LLP					X
23.1	Consent of Fenwick & West LLP (contained in Exhibit 5.1)					X
23.2	Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm					X
24.1	Power of Attorney (included on the signature page to this Registration Statement)					X
99.1	2019 Equity Incentive Plan and forms of award agreements thereunder	S-1/A	333-231837	10.3	6/14/2019
99.2	2019 Employee Stock Purchase Plan and forms of award agreements thereunder	S-1/A	333-231837	10.4	6/14/2019
107	Filing Fee Table					X

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Waltham, Commonwealth of Massachusetts, on this 24th day of February, 2022.

MORPHIC HOLDING, INC.

By:	/s/ Praveen Tipirneni
	Praveen Tipirneni
	President and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Praveen P. Tipirneni and William D. DeVaul, and each of them, as his or her true and lawful attorney-in-fact and agent with full power of substitution, for him or her in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and

purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

Signature	Title	Date
/s/ Praveen P. Tipirneni	President, Chief Executive Officer and Director (Principal Executive Officer)	February 24, 2022
Praveen P. Tipirneni, M.D.
/s/ Marc Schegerin	Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)	February 24, 2022
Marc Schegerin, M.D.
/s/ Robert E. Farrell, Jr.	Chief Accounting Officer (Principal Accounting Officer)	February 24, 2022
Robert E. Farrell, Jr., CPA
/s/ Norbert Bischofberger	Director	February 24, 2022
Norbert Bischofberger, Ph.D.
/s/ Gustav Christensen	Director	February 24, 2022
Gustav Christensen
/s/ Martin Edwards	Director	February 24, 2022
Martin Edwards
/s/ Susannah Gray	Director	February 24, 2022
Susannah Gray
/s/ Nilesh Kumar	Director	February 24, 2022
Nilesh Kumar, Ph.D.
/s/ Nisha Nanda	Director	February 24, 2022
Nisha Nanda, Ph.D.
/s/ Amir Nashat	Director	February 24, 2022
Amir Nashat
/s/ Joseph P. Slattery	Director	February 24, 2022
Joseph P. Slattery, CPA
/s/ Timothy A, Springer	Director	February 24, 2022
Timothy A, Springer, Ph.D.